Zimmer Partners’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-95,704	Closed	-$811K	–	172
2024 Q4	$811K	Hold	95,704	–	–	0.01%	135
2024 Q3	$1.11M	Buy	95,704 +33,000	+53%	+$382K	0.02%	134
2024 Q2	$739K	Sell	62,704 -7,296	-10%	-$85.9K	0.01%	140
2024 Q1	$830K	Buy	+70,000	New	+$830K	0.02%	121